Patients diagnosed with metastatic melanoma. Individuals with advanced colorectal cancer. Patients with non-small cell lung cancer (NSCLC).

Positive Result: Indicates the presence of the mutation and potential benefit from targeted therapy. Negative Result: Indicates the absence of the mutation, suggesting other treatment options.

BRAF V600 Mutation Test Price | Lahalak Medical Platform

Ensure the most effective treatment plan with precise BRAF V600 mutation testing. This molecular analysis helps oncologists identify eligibility for targeted therapies, optimizing cancer care and improving clinical outcomes significantly.

Scientific name: BRAF V600 Mutation Molecular Testing

Advanced molecular test detecting BRAF gene mutations in tumor tissue. It is essential for determining eligibility for BRAF/MEK inhibitors in melanoma, colorectal, and lung cancer patients.

BRAF V600 Mutation Molecular Testing - Precision Testing for Targeted Therapy

Service type Molecular Genetic Test

Duration 15-30 minutes (Sampling)

Fasting Fasting is not required

Included Services

DNA extraction from sample
Gene sequence analysis
Detailed medical result report

Medical Service Information

Why is this test performed?

To determine patient eligibility for BRAF and MEK inhibitors.
To assist in the diagnosis of specific types of melanoma.
To guide treatment decisions for colorectal and lung cancers.

Target Groups

Patients diagnosed with metastatic melanoma.
Individuals with advanced colorectal cancer.
Patients with non-small cell lung cancer (NSCLC).

Interpreting Results

Positive Result: Indicates the presence of the mutation and potential benefit from targeted therapy.
Negative Result: Indicates the absence of the mutation, suggesting other treatment options.